제넥신, NH투자증권 Corporate Day 참석(국내)

Hyleukin-7 : Long-Acting IL-7v

 ＊ Longer in vivo half-life than IL-7

   - FcRn-mediated recycling of IgG4

   - Reduced renal clearance due to size increase

 ＊ Higher productivity than IL-7

   - hyFc fusion to IL-7

 ＊ Higher protein stability

   - N-terminal engineering

- 첨부자료에서 발췌 -